JP2024525691A5 - - Google Patents

Info

Publication number
JP2024525691A5
JP2024525691A5 JP2024501538A JP2024501538A JP2024525691A5 JP 2024525691 A5 JP2024525691 A5 JP 2024525691A5 JP 2024501538 A JP2024501538 A JP 2024501538A JP 2024501538 A JP2024501538 A JP 2024501538A JP 2024525691 A5 JP2024525691 A5 JP 2024525691A5
Authority
JP
Japan
Prior art keywords
polypeptide
self
ferritin
mutations
assembling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024501538A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024525691A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2022/051084 external-priority patent/WO2023035056A1/en
Publication of JP2024525691A publication Critical patent/JP2024525691A/ja
Publication of JP2024525691A5 publication Critical patent/JP2024525691A5/ja
Pending legal-status Critical Current

Links

JP2024501538A 2021-07-12 2022-07-12 最適化されたMultabody構築物、組成物、及び方法 Pending JP2024525691A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163220920P 2021-07-12 2021-07-12
US63/220,920 2021-07-12
US202163289016P 2021-12-13 2021-12-13
US63/289,016 2021-12-13
PCT/CA2022/051084 WO2023035056A1 (en) 2021-07-12 2022-07-12 Optimized multabody constructs, compositions, and methods

Publications (2)

Publication Number Publication Date
JP2024525691A JP2024525691A (ja) 2024-07-12
JP2024525691A5 true JP2024525691A5 (cg-RX-API-DMAC7.html) 2025-11-14

Family

ID=85506055

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024501538A Pending JP2024525691A (ja) 2021-07-12 2022-07-12 最適化されたMultabody構築物、組成物、及び方法

Country Status (8)

Country Link
US (1) US20250276070A1 (cg-RX-API-DMAC7.html)
EP (1) EP4370558A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024525691A (cg-RX-API-DMAC7.html)
KR (1) KR20240032875A (cg-RX-API-DMAC7.html)
AU (1) AU2022341839A1 (cg-RX-API-DMAC7.html)
CA (1) CA3226040A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024000662A (cg-RX-API-DMAC7.html)
WO (1) WO2023035056A1 (cg-RX-API-DMAC7.html)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3774925A1 (en) * 2018-04-13 2021-02-17 Institut national de la santé et de la recherche médicale (INSERM) Fc-engineered anti-human ige antibodies and methods of use
CA3149320A1 (en) * 2019-08-01 2021-02-04 The Hospital For Sick Children Multi-valent and multi-specific nanoparticle platforms and methods
US11624864B2 (en) * 2020-04-15 2023-04-11 Meta Platforms Technologies, Llc Optical device including optically anisotropic molecules having intermediate pretilt angles
MX2023004023A (es) * 2020-10-09 2023-07-07 Hospital For Sick Children Polipéptidos que eligen como objetivo a sars-cov-2 y composiciones y métodos relacionados.
CN117157328A (zh) * 2021-01-28 2023-12-01 儿童医院 Multabody构建体、组合物和方法

Similar Documents

Publication Publication Date Title
CA3031082C (en) Bispecific proteins and methods for preparing same
CN108699136B (zh) 结合cd3和psma的异二聚抗体
US11827701B2 (en) IL-6 binding molecules
JP2023123726A5 (cg-RX-API-DMAC7.html)
RU2019108429A (ru) Модифицированные асимметричные антитела, связывающие fc-рецептор, и способы их применения
JP2009517006A5 (cg-RX-API-DMAC7.html)
JP5818804B2 (ja) ヒトil−22raに対するヒト化抗体
JP2024150674A5 (cg-RX-API-DMAC7.html)
JP2019530434A5 (cg-RX-API-DMAC7.html)
JP2016508153A5 (cg-RX-API-DMAC7.html)
JP2018526981A5 (cg-RX-API-DMAC7.html)
JP6162319B2 (ja) ヒト化抗n2抗体
JP2021534797A5 (cg-RX-API-DMAC7.html)
JP2021521781A5 (cg-RX-API-DMAC7.html)
JP2022549172A5 (cg-RX-API-DMAC7.html)
JP2022538089A5 (cg-RX-API-DMAC7.html)
JP2024504777A5 (cg-RX-API-DMAC7.html)
JP2021518132A5 (cg-RX-API-DMAC7.html)
JP2021525059A5 (cg-RX-API-DMAC7.html)
US20250011428A1 (en) Engineered fc variants
Wang et al. New directions for half-life extension of protein therapeutics: the rise of antibody Fc domains and fragments
US20260098090A1 (en) Fusions with cd8 antigen binding molecules for treating chronic viral infection
IL318098A (en) IGE-FCER pushers
US20260055171A1 (en) Vegf antagonists and methods of use thereof
RU2024102228A (ru) Оптимизированные конструкции, композиции и способы на основе multabody